Greater Manchester MH Foundation trust
Information Governance Department
Bury New Road
Prestwich
Manchester
Tel 0161 358 1760
foi@gmmh.nhs.uk
www.gmmh.nhs.uk
Our reference: /FOI D9623
23rd June 2020
Dear Wendy
RE: FREEDOM OF INFORMATION ACT 2000 – INFORMATION REQUEST - REF: D9623
Please find our Trust’s response in relation to your request for information under the Freedom of Information Act
Please provide ECT information under the FOI act to the following questions: -
Please supply patient’s information ECT leaflet.
This is currently being updated and is unavailable at this time.
Please supply patient ECT consent form.
This is currently being updated and is unavailable at this time.
Please supply any ECT reports/investigations
How many ECT in 2019?
There were 104 ECT treatments received
What proportion of patients were men/women?
How old were they?
What were the diagnoses and in what proportions?
What proportion of patients were classified BAME?
How many were receiving ECT for the first time?
There were 104 first ECT treatments received
How many patients consented to ECT? All
How many ECT complaints were investigated outside the NHS and CCG?
0 – none received
How many patients died during or soon after ECT and what was the cause (whether or not ECT was considered the cause)?
How many patients died a few months after ECT and what was the cause (whether or not ECT was considered the cause)?
How many patients died by suicide within a few months of receiving ECT (whether or not ECT was considered the cause)?
How many patients have suffered complications during and after ECT and what were those complications?
Have there been any formal complaints from patients/relatives about ECT? No
If so, what was their concerns? N/A
How many patients report memory loss/loss of cognitive function?
We do not routinely record this information
What tests are used to assess memory loss/loss of cognitive function?
Assessment of memory loss/loss of cognitive function will include
a) A clinical assessment (history of cognitive decline, delineation of symptoms, duration of illness, assessment of underlying physical illnesses/mental illness/medications)
b) Other investigations as clinically indicated which may include
Use of assessment tools eg Addenbrookes cognitive exam/ Mini Addenbrookes Cognitive exam
Neuropsychological testing (battery of tests to be determined by neuropsychologists
Rating scales of mood
Functional assessments
Carer assessments
ECG
Clinically determined neuroimaging eg CT brain/MRI brain/SPECT/DAT scan
Haematological investigations including (non-exhaustive list as choice may include other clinically indicated tests) FBC, U+E, LFT, Calcium and bone profile, TFT, Glc/HbA1c, Lipids, B12, Folate
Other investigations as clinically indicated eg EEG
Have MRI or CT scans been used before and after ECT?
GMMH does not carry out these scans as we are not an acute Trust
If so what was the conclusion? N/A
How does the Trust plan to prevent ECT in the future?
N/A
For any question not answered the following applies:
The system used by GMMH does not separate incidents of this category. To locate and collate these incidents would require a member of staff to review each incident to confirm whether it was relevant and it would take too long to review all incidents that have been reported across the trust. All the Datix data (incidents) would need to be linked individually to the PARIS data (patient information) to get to these characteristics. This would take more than the appropriate limit of 18 staffing hours and therefore it has been decided that this information is subject to an exemption in accordance with Section 12 (1) of the Freedom of Information Act – the cost of compliance exceeds the appropriate limit.
Please provide SERIOUS INCIDENT information under the FOI act to the following questions: -
Please supply SERIOUS INCIDENT REPORTS patient’s information leaflet. N/A
Please supply patient SERIOUS INCIDENT REPORTS consent form. N/A
Please supply any serious incident reports/investigations
Cannot supply as it will breach confidentiality of individuals
How many SERIOUS INCIDENT REPORTS in 2019? 254
What proportion of patients were men/women?
How old were they?
What were the diagnoses and in what proportions?
What proportion of patients were classified BAME? Data is not broken down to this level.
How many were receiving SERIOUS INCIDENT REPORTS for the first time?
How many patients consented to SERIOUS INCIDENT REPORTS?
We do not require consent for the Trust to complete a review as this is for Trust learning.
How many SERIUOS INCIDENT REPORTS were investigated outside the NHS and CCG? 0
How many patients died during or soon after SERIOUS INCIDENT REPORTS and what was the cause (whether or not SERIOUS INCIDENT REPORTS was considered the cause)?
How many patients died a few months after SERIOUS INCIDENT REPORTS and what was the cause (whether or not SERIOUS INCIDENT REPORTS was considered the cause)?
How many patients died by suicide within a few months of receiving SERIOUS INCIDENT REPORTS (whether or not SERIOUS INCIDENT REPORTS was considered the cause)?
How many patients have suffered complications during and after SERIOUS INCIDENT REPORTS and what were those complications?
Have there been any formal complaints from patients/relatives about SERIOUS INCIDENT
REPORTS? Yes
If so, what was their concerns? Unhappy with content
How many patients report memory loss/loss of cognitive function?
N/A under this heading
What tests are used to assess memory loss/loss of cognitive function? See answer to Q19 under ECT heading.
Have MRI or CT scans been used before and after SERIOUS INCIDENT REPORTS? N/A
If so what was the conclusion? N/A
How does the Trust plan to prevent SERIOUS INCIDENTS in the future?
We hold learning events and share learning to review how serious incidents can be avoided in the future, we also share learning from serious incidents via positive lessons learned 7-minute briefings.
For any question not answered the following applies:
The system used by GMMH does not separate incidents of this category. To locate and collate these incidents would require a member of staff to review each incident to confirm whether it was relevant and it would take too long to review all incidents that have been reported across the trust. All the Datix data (incidents) would need to be linked individually to the PARIS data (patient information) to get to these characteristics. This would take more than the appropriate limit of 18 staffing hours and therefore it has been decided that this information is subject to an exemption in accordance with Section 12 (1) of the Freedom of Information Act – the cost of compliance exceeds the appropriate limit
Please provide restraints information under the FOI act to the following questions: -
Please supply RESTRAINTS patient’s information leaflet. N/A
Please supply patient RESTRAINTS consent form. N/A
Please supply any Restraints/investigations N/A
How many RESTRAINTS in 2019? 4378
What proportion of patients were men/women?
How old were they?
What were the diagnoses and in what proportions?
What proportion of patients were classified BAME?
How many were receiving RESTRAINTS for the first time?
How many patients consented to RESTRAINTS?
N/A
How many RESTRAINTS were investigated outside the NHS and CCG ? 0
How many patients died during or soon after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)?
How many patients died a few months after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)?
How many patients died by suicide within a few months of receiving RESTRAINTS (whether or not RESTRAINTS was considered the cause)?
How many patients have suffered complications during and after RESTRAINTS and what were those complications?
Have there been any formal complaints from patients/relatives about RESTRAINTS? 2
If so, what was their concerns?
How many patients report memory loss/loss of cognitive function? Data not captured
What tests are used to assess memory loss/loss of cognitive function? See answer to Q19 under ECT heading.
Have MRI or CT scans been used before and after RESTRAINTS?
N/A to the Trust
If so what was the conclusion? N/A
How does the Trust plan to reduce restraints in the future?
N/A
For any question not answered the following applies:
The system used by GMMH does not separate incidents of this category. To locate and collate these incidents would require a member of staff to review each incident to confirm whether it was relevant and it would take too long to review all incidents that have been reported across the trust. All the Datix data (incidents) would need to be linked individually to the PARIS data (patient information) to get to these characteristics. This would take more than the appropriate limit of 18 staffing hours and therefore it has been decided that this information is subject to an exemption in accordance with Section 12 (1) of the Freedom of Information Act – the cost of compliance exceeds the appropriate limit
Please provide SECLUSION information under the FOI act to the following questions: -
Please supply patient’s information SECLUSION leaflet. N/A
Please supply patient SECLUSION consent form. N/A
Please supply any SECLUSION reports/investigations N/A
How many SECLUSION in 2019? 923
What proportion of patients were men/women?
How old were they?
What were the diagnoses and in what proportions?
What proportion of patients were classified BAME?
How many were receiving SECLUSION for the first time?
How many patients consented to SECLUSION?
How many SECLUSIONS were investigated outside the NHS and CCG ?
How many patients died during or soon after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)?
How many patients died a few months after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)?
How many patients died by suicide within a few months of receiving SECLUSION (whether or not SECLUSION was considered the cause)?
How many patients have suffered complications during and after SECLUSION and what were those complications?
Have there been any formal complaints from patients/relatives about SECLUSION? 0
If so, what was their concerns? N/A
How many patients report memory loss/loss of cognitive function? N/A
What tests are used to assess memory loss/loss of cognitive function? See answer to Q19 under ECT heading.
Have MRI or CT scans been used before and after SECLUSION?
N/A to the trust
If so what was the conclusion? N/A
How does the Trust plan to prevent SECLUSION in the future? N/A
For any question not answered the following applies:
The system used by GMMH does not separate incidents of this category. To locate and collate these incidents would require a member of staff to review each incident to confirm whether it was relevant and it would take too long to review all incidents that have been reported across the trust. All the Datix data (incidents) would need to be linked individually to the PARIS data (patient information) to get to these characteristics. This would take more than the appropriate limit of 18 staffing hours and therefore it has been decided that this information is subject to an exemption in accordance with Section 12 (1) of the Freedom of Information Act – the cost of compliance exceeds the appropriate limit.
Please provide MEDICATION ERRORS information under the FOI act to the following questions: -
Please supply patient’s information MEDICATION ERRORS leaflet. N/A
Please supply patient MEDICATION ERRORS consent form. N/A
Please supply any MEDICATION ERRORS reports/investigations This would breach confidentiality of individuals
How many MEDICATION ERRORS in 2019? 1608
What proportion of patients were men/women?
How old were they?
What were the diagnoses and in what proportions?
What proportion of patients were classified BAME?
How many were receiving MEDICATION ERRORS for the first time?
How many patients consented to MEDICATION ERRORS? N/A
How many MEDICATION ERRORS S were investigated outside the NHS and CCG? N/A
How many patients died during or soon after MEDICATION ERRORS and what was the cause
(whether or not MEDICATION ERRORS was considered the cause)?
0 when we looked at Medication errors that had resulted in death
How many patients died a few months after MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)?
How many patients died by suicide within a few months of receiving MEDICATION ERRORS (whether or not MEDICATION ERRORS was considered the cause)?
How many patients have suffered complications during and after MEDICATION ERRORS and what were those complications?
Have there been any formal complaints from patients/relatives about MEDICATION ERRORS? Yes
If so, what was their concerns?
Questions about medication and treatment
Wrong dosage of medication given
Carer has concerns about medication labelled incorrectly.
Unhappy about quality of care provided by CPN
Complaint regarding lack of care post discharge with no follow up or care coordinator.
Has suffered a number of serious health issues since discharge from hospital in 2013.
Parents unhappy with the level of care provided to their child and the years of misdiagnosis and incorrect treatment
How many patients report memory loss/loss of cognitive function?
We do not routinely record this information
What tests are used to assess memory loss/loss of cognitive function? See answer to Q19 under ECT heading.
Have MRI or CT scans been used before and after MEDICATION ERRORS? N/A to the Trust
If so what was the conclusion? N/A
How does the Trust plan to prevent MEDICATION ERRORS in the future?
Through staff training around medicines management. We share learning to review how medication errors can be avoided in the future, we also share learning from medications errors via positive lessons learned 7 minute briefings.
For any question not answered the following applies:
The system used by GMMH does not separate incidents of this category. To locate and collate these incidents would require a member of staff to review each incident to confirm whether it was relevant and it would take too long to review all incidents that have been reported across the trust. All the Datix data (incidents) would need to be linked individually to the PARIS data (patient information) to get to these characteristics. This would take more than the appropriate limit of 18 staffing hours and therefore it has been decided that this information is subject to an exemption in accordance with Section 12 (1) of the Freedom of Information Act – the cost of compliance exceeds the appropriate limit.
I hope the information provided above is to your satisfaction. If you are unhappy with the way, the Trust has handled your request you may request an internal review.
If you require an internal review please write to Sarah McDonald, Head of IM&T Service Delivery, at the address above, who will arrange a review of your case.
If you are not happy with the outcome of the internal review you have the right to apply directly to the Information Commissioner: Information Commissioner’s Office, Wycliffe House, Water Lane, Wilmslow, Cheshire, SK9 5AF.
Yours sincerely
The FOI Team
Freedom of Information Department
Greater Manchester MH NHS Foundation Trust
Please note:
The information supplied to you continues to be protected by the Copyright, Designs and Patents Act 1988. You are free to use it for your own purposes, including any non-commercial research you are doing and for the purposes of news reporting. Any other re-use, for example commercial publication and subscription charge, would require the permission of the copyright holder. In accordance with the Re-Use of Public Sector Information Regulations 2015, information provided to you may not be used for commercial publication, subscription charge or sold on to a third party.
For any named personnel provided in this Freedom of Information response, they do not wish to receive direct marketing, to do so would contravene GDPR and the Data Protection Act 2018.